Fritextsökning
Innehållstyper
-
A tiny animal with great importance
From the mythical Ganges River to the less sacred, but considerably cleaner waters in KI's aquariums in Solna. The little zebrafish has made an unconscious care...
-
No longer afraid of the dentist.
Teaching robot with piezo technology
-
Tio life science-projekt får miljonanslag – ny utlysning öppnar
En rad life science-projekt har fått miljonanslag i ett svenskt proof of concept-program. 13 januari öppnar en ny utlysning.
-
AstraZeneca to use American AI platform for cancer trials
In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.
-
Neogap får patent i Kina för t-cellsmetod
Neogap Therapeutics, som utvecklar immunterapier mot cancer, har beviljats ett kinesiskt patent för sin metod att producera tumörspecifika T-celler.
-
Hur man uppnår optimal ångkvalitet?
Optimal ångkvalitet är en avgörande faktor i industriella processer där driftsäkerhet, energieffektivitet och produktkvalitet är viktiga faktorer. Genom att säk...
-
Large study: The benefits and risks of obesity medications
Medications such as Ozempic can reduce the risk of a range of different diseases and health conditions but also increase the risk of others. This is according t...
-
New moves around Nykode's management – withdrawal of resignations
Norwegian Nykode Therapeutics is reinstating members of the management team who previously announced their resignations.
-
Karriärcoachen: Så får du AI att söka jobbet åt dig
För att använda AI effektivt måste vi ändra vårt tankesätt för hur vi kommunicerar. Annars får vi bara döda motivationsbrev och döda resuméer. Det anser karriär...
-
Planerar ni en klinisk studie? Tänk på det här.
Att genomföra en klinisk studie är en komplex och resurskrävande process som kräver noggrann planering och riskhantering. För företag inom life science-sektorn ...
-
Nanexa finalist i Fierce Innovation Awards
Uppsalabolaget Nanexa har utsetts till finalist i den internationella tävlingen Fierce Innovation Awards Life Sciences. Bolaget uppmärksammas i kategorin Drug D...
-
MSD discontinues development of cancer drugs after trial failures
MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.
-
Non-destructive testing and assembly control
Assess complete assembly.
-
Vaccine skeptic David Geier to lead study on link to autism
The American government is to launch a study on whether vaccines cause autism – and has appointed a well-known vaccine skeptic to lead the analysis.
-
She is CSL Behring's new Nordic General Manager
Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.
-
Moderna develops mRNA vaccine against norovirus
A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...
-
Security flaw in Swedish breast cancer screening software – woman passed away
A lack of safeguard in Sectra's software led to a woman with breast cancer receiving an incorrect diagnosis. She later passed away. The software is used in 20 o...
-
Björn Arvidsson: ”Långsiktiga satsningar är inga lyxprojekt utan framtidslöften”
Life science kan bli Sveriges nästa stora kapitel, men för det krävs uthållighet och politiskt mod, skriver Björn Arvidsson i en krönika.
-
LINK Medical recruits Swedish CEO
The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.
-
Grönt ljus för diabetespiller för att reducera hjärtrisker
FDA godkänner Novo Nordisks Rybelsus för behandling av allvarliga hjärt-kärlhändelser hos vuxna med typ 2-diabetes. Det är första gången ett oralt GLP-1-läkemed...
-
ZEISS continues to drive digital era forward in ophthalmology
2 million digitally planned cataract cases in the U.S. alone.
-
New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"
For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
BREAKING